Automated Cell Culture Market Size and Growth Forecast: Global Insights and Analysis

Report ID : 1292559 | Published : June 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Automated Cell Culture Market is categorized based on Product Type (Consumables, Instruments, Software, Services) and Cell Type (Mammalian Cells, Microbial Cells, Stem Cells, Plant Cells) and Application (Biopharmaceutical Production, Toxicity Testing, Regenerative Medicine, Stem Cell Research) and End User (Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Contract Research Organizations) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

As of 2023, the Automated Cell Culture Market size stood at $5.3 billion and is expected to attain $12.4 billion by 2033, growing at a 8.7% CAGR from 2024 through 2033. The report includes diverse segments and offers an analysis of trends and factors substantially impacting the market.

In biopharmaceutical development, regenerative medicine, and personalized healthcare, there is an increasing demand for advanced cellular technologies, which is driving the growth of the automated cell culture market. The emerging complexity of biological systems is necessitating more precise, reproducible, and scalable solutions, thus, researchers are turning towards automation for cell culture processes. Such innovations not only optimize the workflows but also minimize human error, which improves the reliability of experimental outcomes.

In addition, increased funding towards life science research and heightened focus on drug discovery and development is further driving adoption of automated cell culture systems. More and more institutions and laboratories are starting to appreciate the contribution of automation towards faster research timelines and enhanced productivity. Consequently, there is an increased supply in the automated cell culture market, as many sophisticated automation platforms are being introduced to serve basic research activities as well as complex therapeutic production.

As the practices in cell cultures are integrated with various technologies and methodologies, the advancements will be extremely beneficial for the stakeholders within the biotechnology and healthcare sectors. Automated cell culture systems lie both within innovation and automated cell culture technologies, as they give rise to promising breakthroughs capable of transforming the biomedicinal investigative domains and clinical medicine.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Lonza Group, Becton, Dickinson and Company, GE Healthcare, Sartorius AG, Roche Holding AG, Promega Corporation, Sigma-Aldrich Corporation, Waters Corporation
SEGMENTS COVERED	By Product Type - Consumables, Instruments, Software, Services By Cell Type - Mammalian Cells, Microbial Cells, Stem Cells, Plant Cells By Application - Biopharmaceutical Production, Toxicity Testing, Regenerative Medicine, Stem Cell Research By End User - Pharmaceutical Companies, Biotechnology Companies, Research Institutions, Contract Research Organizations By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Automated Cell Culture Market Dynamics

The Automated Cell Culture Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Automated Cell Culture Market

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Thermo Fisher Scientific
• Merck KGaA
• Corning Incorporated
• Lonza Group
• Becton
• Dickinson and Company
• GE Healthcare
• Sartorius AG
• Roche Holding AG
• Promega Corporation
• Sigma-Aldrich Corporation
• Waters Corporation

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved